“Our commitment to information security must be unwavering,” said Coleman Stavish, Proscia’s Chief Technology Officer. “Leading life sciences organizations and diagnostic laboratories rely on our Concentriq platform for patient-centric, mission-critical work. Achieving ISO 27001 certification gives them even more trust in our company.”
Proscia’s Concentriq® is an enterprise pathology platform that unifies people, data, and applications. Securely deployed in the cloud, it delivers the performance and scale needed to drive routine digital pathology operations for even the largest organizations.
The company has further established trust in its products by demonstrating compliance with global regulatory and quality standards. Its Concentriq Dx is CE-marked under IVDR and additionally has regulatory clearances in the United Kingdom, Switzerland, and Canada. Proscia also earned Medical Device Single Audit Program certification, which verifies its conformity with the ISO 13485 standard for medical device quality management systems.
About Proscia
Proscia is a software company accelerating the transformation to digital pathology to change the way we understand diseases like cancer. Its Concentriq enterprise pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline, unlocking new insights that accelerate R&D, improve patient outcomes, and fulfill the promise of precision care. Leading diagnostic laboratories and 14 of the top 20 pharmaceutical companies rely on Proscia’s software each day. For more information, visit proscia.com.
Media Contact
Sydney Fenkell, Proscia, 1 215-816-3436, [email protected], www.proscia.com
SOURCE Proscia
